By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that it has completed its $34 million all-cash purchase of EraGen Biosciences.

Luminex said the acquisition of the Madison, Wis.-based molecular diagnostics firm would add between $5 million and $7 million in revenues to Luminex in 2011. The deal is expected to be dilutive to 2011 earnings and accretive to 2012 earnings on a GAAP basis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.